Phase II study of irinotecan and etoposide in patients with metastatic non-small-cell lung cancer.
Oshita F, Noda K, Nishiwaki Y, Fujita A, Kurita Y, Nakabayashi T, Tobise K, Abe S, Suzuki S, Hayashi I, Kawakami Y, Matsuda T, Tsuchiya S, Takahashi S, Tamura T, Saijo N.
Oshita F, et al. Among authors: saijo n.
J Clin Oncol. 1997 Jan;15(1):304-9. doi: 10.1200/JCO.1997.15.1.304.
J Clin Oncol. 1997.
PMID: 8996157
Clinical Trial.